9-2039776-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_003070.5(SMARCA2):c.699_707del(p.Gln236_Gln238del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.004 in 1,596,338 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q223Q) has been classified as Likely benign.
Frequency
Consequence
NM_003070.5 inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.699_707del | p.Gln236_Gln238del | inframe_deletion | 4/34 | ENST00000349721.8 | |
SMARCA2 | NM_001289396.1 | c.699_707del | p.Gln236_Gln238del | inframe_deletion | 4/34 | ||
SMARCA2 | NM_001289397.2 | c.699_707del | p.Gln236_Gln238del | inframe_deletion | 4/33 | ||
SMARCA2 | NM_139045.4 | c.699_707del | p.Gln236_Gln238del | inframe_deletion | 4/33 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMARCA2 | ENST00000349721.8 | c.699_707del | p.Gln236_Gln238del | inframe_deletion | 4/34 | 5 | NM_003070.5 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.00530 AC: 798AN: 150428Hom.: 4 Cov.: 26
GnomAD4 exome AF: 0.00386 AC: 5586AN: 1445810Hom.: 7 AF XY: 0.00391 AC XY: 2813AN XY: 718568
GnomAD4 genome ? AF: 0.00529 AC: 797AN: 150528Hom.: 4 Cov.: 26 AF XY: 0.00518 AC XY: 381AN XY: 73486
ClinVar
Submissions by phenotype
not provided Benign:6
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jul 07, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | SMARCA2: BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 31, 2019 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Nicolaides-Baraitser syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Jun 06, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at